Arbutus Biopharma Corp
NASDAQ:ABUS 4:00:00 PM EDT
| Market Cap (Intraday) | 868.40M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $4.36 |
| 50-Day MA | $3.56 |
| 200-Day MA | $3.40 |
Arbutus Biopharma Corp Stock, NASDAQ:ABUS
701 Veterans Circle, Suite 100, Warminster, Pennsylvania 18974
United States of America
Phone: +1.267.469.0914
Number of Employees: 73
Description
Arbutus Biopharma Corp. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics that target specific viral diseases. It focuses on the Hepatitis B virus, SARS-CoV-2, and other coronaviruses. The company was founded on October 6, 2005 and is headquartered in Warminster, PA.